ARMK vs CNM

ARMK's deterministic health signals are concerning, with a Piotroski F-Score of 4/9 indicating marginal financial stability and no available Altman Z-Score to confirm solvency safety. The stock trades at a significant premium to its Graham Number of $18.06 and intrinsic value of $8.47, supported by strong revenue growth and analyst optimism, but profitability and earnings trends are inconsistent. While the company shows top-line momentum and operates efficiently relative to peers in a highly leveraged sector, weak margins, declining earnings, and technical bearishness temper enthusiasm. Analysts recommend a 'buy', yet insider sentiment and trading activity are neutral, suggesting no strong conviction from insiders.

CNM exhibits strong operational health with a Piotroski F-Score of 7/9, indicating robust financial stability and efficiency. However, the stock is currently trading at $49.50, which is slightly above its growth-based intrinsic value of $47.70 and significantly above its defensive Graham Number of $23.45. While earnings are growing (9.10% YoY), the company is facing a concerning trend of declining revenues (-6.90% YoY), suggesting a reliance on cost-cutting rather than organic expansion. Technical trends and insider sentiment are currently bearish, offsetting the optimistic analyst target of $60.88.